Bone loss returns to pre-AI levels, when AI is discontinued
 

We heard yesterday here in San Antonio, that studies are showing bone density loss due to AI treatment reverses when the drug is discontinued. Essentially, your bone density will return to the level that it was at when you started your AI treatment. This is very promising to learn that bone density loss is not necessarily a permanent side effect of Aromatase Inhibitors!

That's the kind of news I like to here. That does sound very promising. Thanks for taking the time to share that.

Chelee

Me too.
 

News I like to hear, too. I have my 2nd bone density test in January... fingers crossed.

Karen

Interesting post